Last Updated: November 11, 2026

CEFTAZIDIME IN DEXTROSE CONTAINER Drug Patent Profile

Name: CEFTAZIDIME IN DEXTROSE CONTAINER Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Ceftazidime In Dextrose Container, and when can generic versions of Ceftazidime In Dextrose Container launch?

Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ceftazidime In Dextrose Container

A generic version of CEFTAZIDIME IN DEXTROSE CONTAINER was approved as ceftazidime by ACS DOBFAR on November 20^th, 1985.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CEFTAZIDIME IN DEXTROSE CONTAINER?
What are the global sales for CEFTAZIDIME IN DEXTROSE CONTAINER?
What is Average Wholesale Price for CEFTAZIDIME IN DEXTROSE CONTAINER?

Summary for CEFTAZIDIME IN DEXTROSE CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	80
Patent Applications:	6,040
DailyMed Link:	CEFTAZIDIME IN DEXTROSE CONTAINER at DailyMed

Drug patent expirations by year for CEFTAZIDIME IN DEXTROSE CONTAINER

Recent Clinical Trials for CEFTAZIDIME IN DEXTROSE CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GIRCI Auvergne Rhne-Alpes	NA
Direction Gnrale de l'Offre de Soins	NA
Centre Hospitalier Universitaire de Saint Etienne	NA

See all CEFTAZIDIME IN DEXTROSE CONTAINER clinical trials

US Patents and Regulatory Information for CEFTAZIDIME IN DEXTROSE CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	CEFTAZIDIME IN DEXTROSE CONTAINER	ceftazidime	INJECTABLE;INJECTION	050823-001	Jun 13, 2011		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
B Braun	CEFTAZIDIME IN DEXTROSE CONTAINER	ceftazidime	INJECTABLE;INJECTION	050823-002	Jun 13, 2011		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.